OSP.ASX looks like sell off died already . #OSP #ASX
About the company Osprey Medical Inc. (OSP) is a medical device company with operations based in USA. The Company is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures.
Fair Value Estimate 0.052c if it holds this level
Trade active
Minnesota, United States and Melbourne, Australia – 29 October 2020 - Osprey Medical Inc. (ASX:OSP) (Osprey or the Company) today released its Appendix 4C – Quarterly Cash Flow Report for the period ending 30 September 2020.
Key Highlights
• Strong month on month growth in unit sales over the quarter despite COVID interruptions, on track to return to preCOVID levels • Expanding sales under milestone distribution agreements signed with GE Healthcare to exclusively distribute Osprey product across the EMEA region and Regional Health Care Group to exclusively distribute across Australia & New Zealand • Received European CE Marking approval for the 2nd generation DyeVert Power XT system • Business remains well capitalised with a cash balance of US7.0m / A$9.8 m1 as of 30 September 2020, with a further A$1.7 m funds raised via options exercised in October 2020
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.